Brief: Jiangsu Recbio Technology Says HY Loss Attributable Rmb272.5 Million
25/08/2023 14:21
Aug 25 (Reuters) - Jiangsu Recbio Technology Co Ltd
2179.HK :
* HY LOSS ATTRIBUTABLE RMB272.5 MILLION VERSUS LOSS RMB349.7
MILLION
* HY OTHER INCOME AND GAINS RMB59.9 MILLION VERSUS RMB78.6
MILLION
Source text for Eikon: ID:nHKS2FY6Gd
Further company coverage: 2179.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jiangsu Recbio Technology
See all newsBrief: Jiangsu Recbio Technology To Re-Plan Timetable For HPV Vaccine Marketing Application
Brief: Jiangsu Recbio Technology Says New Drug Application For REC610 Shingles Vaccine Accepted By NMPA
Brief: Jiangsu Recbio Technology Says Liu Yong Resigned As Chair
Brief: Jiangsu Recbio Technology Says Li Bu Resigned As Executive Director
Brief: Jiangsu Recbio Technology Says Acceptance By CSRC Of Application Materials For Issuance Of Shares